(S (NP (NNP Melanoma)) (VP (VBZ is) (NP (NP (DT the) (JJS deadliest) (NN form)) (PP (IN of) (NP (NN skin) (NN cancer))))) (. .))
(S (SBAR (IN While) (FRAG (ADJP (JJ curable) (PP (IN with) (NP (JJ early) (NN detection)))))) (, ,) (NP (RB only) (ADJP (RB highly) (JJ trained)) (NNS specialists)) (VP (VBP are) (ADJP (JJ capable) (PP (IN of) (S (ADVP (RB accurately)) (VP (VBG recognizing) (NP (DT the) (NN disease))))))) (. .))
(S (SBAR (IN As) (S (NP (NN expertise)) (VP (VBZ is) (PP (IN in) (NP (JJ limited) (NN supply)))))) (, ,) (NP (NP (VBN automated) (NNS systems)) (ADJP (JJ capable) (PP (IN of) (S (VP (VBG identifying) (NP (NN disease))))))) (VP (MD could) (VP (VP (VB save) (NP (NNS lives))) (, ,) (VP (VB reduce) (NP (JJ unnecessary) (NNS biopsies))) (, ,) (CC and) (VP (VB reduce) (NP (NNS costs))))) (. .))
(S (PP (IN Toward) (NP (DT this) (NN goal))) (, ,) (NP (PRP we)) (VP (VBP propose) (NP (NP (DT a) (NN system)) (SBAR (WHNP (WDT that)) (S (VP (VBZ combines) (NP (NP (JJ recent) (NNS developments)) (PP (IN in) (NP (JJ deep) (NN learning)))) (PP (IN with) (NP (VBN established) (NML (NN machine) (NN learning)) (NNS approaches))) (, ,) (S (VP (VP (VBG creating) (NP (NP (NNS ensembles)) (PP (IN of) (NP (NP (NNS methods)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (ADJP (JJ capable) (PP (IN of) (S (VP (VBG segmenting) (NP (NN skin) (NNS lesions))))))))))))) (, ,) (CONJP (RB as) (RB well) (IN as)) (VP (VBG analyzing) (NP (NP (DT the) (VBN detected) (NN area) (CC and) (VBG surrounding) (NN tissue)) (PP (IN for) (NP (NN melanoma) (NN detection)))))))))))) (. .))
(S (NP (DT The) (NN system)) (VP (VBZ is) (VP (VBN evaluated) (S (VP (VBG using) (NP (NP (NP (DT the) (JJS largest) (ADJP (RB publicly) (JJ available)) (NN benchmark) (NN dataset)) (PP (IN of) (NP (JJ dermoscopic) (NNS images)))) (, ,) (VP (VBG containing) (NP (NP (CD 900) (NN training)) (CC and) (NP (CD 379) (NN testing) (NNS images))))))))) (. .))
(S (NP (NML (NML (JJ New) (NN state)) (HYPH -) (PP (IN of) (HYPH -) (NP (DT the) (HYPH -) (NN art)))) (NN performance) (NNS levels)) (VP (VBP are) (VP (VBN demonstrated) (, ,) (S (VP (VBG leading) (PP (IN to) (NP (NP (DT an) (NN improvement)) (PP (IN in) (NP (NP (DT the) (NN area)) (PP (PP (IN under) (NP (NP (ADJP (NP (NN receiver) (NN operating)) (JJ characteristic)) (NN curve)) (PP (IN of) (NP (NP (CD 7.5) (NN %)) (-LRB- -LRB-) (NP (NP (CD 0.843)) (PP (FW vs.) (NP (CD 0.783)))) (-RRB- -RRB-))))) (, ,) (PP (IN in) (NP (NP (JJ average) (NN precision)) (PP (IN of) (NP (NP (CD 4) (NN %)) (-LRB- -LRB-) (NP (NP (CD 0.649)) (PP (FW vs.) (NP (CD 0.624)))) (-RRB- -RRB-))))) (, ,) (CC and) (PP (IN in) (NP (NP (NN specificity)) (VP (VBN measured) (PP (IN at) (NP (DT the) (ADJP (RB clinically) (JJ relevant)) (NML (CD 95) (NN %)) (NN sensitivity) (NN operating) (NML (NML (NML (NN point)) (PP (ADVP (ADVP (NP (CD 2.9) (NNS times)) (JJR higher)) (PP (IN than) (NP (DT the) (JJ previous) (NN state)))) (HYPH -) (IN of) (HYPH -) (NP (DT the) (HYPH -) (NN art)))) (-LRB- -LRB-) (NML (CD 36.8) (NN %))) (NN specificity))) (PP (VBN compared) (PP (IN to) (NP (CD 12.5) (NN %))))))) (-RRB- -RRB-)))))))))) (. .))
(S (PP (VBN Compared) (PP (IN to) (NP (NP (DT the) (NN average)) (PP (IN of) (NP (NP (CD 8) (NN expert) (NNS dermatologists)) (PP (IN on) (NP (NP (DT a) (NN subset)) (PP (IN of) (NP (CD 100) (NN test) (NNS images)))))))))) (, ,) (NP (DT the) (VBN proposed) (NN system)) (VP (VBZ produces) (NP (NP (NP (DT a) (JJR higher) (NN accuracy)) (-LRB- -LRB-) (NP (NP (CD 76) (NN %)) (PP (FW vs.) (NP (CD 70.5) (NN %)))) (-RRB- -RRB-)) (, ,) (CC and) (NP (NP (NN specificity) (PRN (-LRB- -LRB-) (NP (NP (CD 62) (NN %)) (PP (FW vs.) (NP (CD 59) (NN %)))) (-RRB- -RRB-))) (VP (VBN evaluated) (PP (IN at) (NP (DT an) (JJ equivalent) (NN sensitivity))) (PRN (-LRB- -LRB-) (NP (CD 82) (NN %)) (-RRB- -RRB-)))))) (. .))
